Pittenger & Anderson Inc Editas Medicine, Inc. Transaction History

Pittenger & Anderson Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$39.71 - $90.58 $2,978 - $6,793	-75 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$28.06 - $37.16 $645 - $854	23 Added 44.23%	75 $2,000
Q3 2019 Nov 14, 2019	BUY	$22.49 - $26.81 $269 - $321	12 Added 30.0%	52 $1,000
Q3 2017 Nov 13, 2017	BUY	$15.81 - $24.01 $632 - $960	40	40 $1,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $151M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.